Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Early Life Sleep Deprivation: Role of Oxido-Inflammatory Processes.

Neuroscience | 2019

The adverse consequences of early-life sleep deprivation on mental health are well recognized, yet many aspects remain unknown, therefore, animal studies can offer useful insights. Male Sprague-Dawley rats at postnatal day (PND) 19 were subjected to sleep deprivation (SD) for 14 days (6-8 hours/day). Control (CON) rats were gently handled. Behavior tests were done on PND33, PND60 and PND90. SD rats exhibited anxiety-like behavior at PND33 and PND60, when compared to CON rats. Depression-like behavior was observed at PND90. Evaluation of oxidative stress and inflammatory markers revealed interesting results. Plasma 8-isoprostane and antioxidant defense enzymes; hemeoxygenase-1, superoxide dismutase, glutathione peroxidase in the prefrontal cortex (PFC), were upregulated in SD rats at PND33 but not at PND90. PFC interleukin-6 protein expression was elevated at PND33 and PND90. PFC mitogen activated protein kinase phosphatase-1 (MKP-1) and p-38 protein expression were upregulated at PND90. PFC expression of glutamate receptor subunits, post synaptic density protein (PSD-95), calcium/calmodulin-dependent protein kinase (CaMKII), and extracellular signal-regulated kinase (ERK1/2), were significantly reduced in SD rats at PND33 and PND90. PFC brain derived neurotrophic factor (BDNF) and cAMP response element binding protein (CREB) were reduced in SD rats at PND90. Our postulation is that SD by increasing PFC oxido-inflammation, negatively affects glutamate receptor subunits and PSD95 expression, which disrupts synapse formation and maturation, potentially causing anxiety-like behavior at PND33. Oxido-inflammation further results in MKP-1 and CaMKII-mediated blockade of ERK1/2 activation, which inhibits CREB dependent BDNF expression. This most likely disrupts neuronal circuit development, leading to depression-like behavior at PND90.

Pubmed ID: 30826520 RIS Download

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


NMDAR2B antibody (antibody)

RRID:AB_1658870

This polyclonal targets NMDAR2B antibody

View all literature mentions

p38 (phospho Y182) antibody (antibody)

RRID:AB_881848

This polyclonal targets p38 (phospho Y182)

View all literature mentions

CREB-1 (240) (antibody)

RRID:AB_631314

This polyclonal targets CREB1

View all literature mentions

p-CaMKII (22B1) (antibody)

RRID:AB_626786

This monoclonal targets Rat CaMKII, phospho (Thr286)

View all literature mentions

CaMKII (M-176) (antibody)

RRID:AB_634551

This polyclonal targets CaMKII (M-176)

View all literature mentions

β-Actin (8H10D10) Mouse mAb (antibody)

RRID:AB_2242334

This monoclonal targets beta-actin

View all literature mentions

MKP-1 Polyclonal Antibody (antibody)

RRID:AB_10986429

This unknown targets MKP-1

View all literature mentions

AMPA Receptor 1 (GluA1) (D4N9V) (antibody)

RRID:AB_2732897

This monoclonal targets AMPA Receptor 1

View all literature mentions

BDNF (N-20) (antibody)

RRID:AB_630940

This monoclonal targets BDNF

View all literature mentions

Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (E10) Mouse mAb (antibody)

RRID:AB_331768

This monoclonal targets Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (E10) Mouse mAb

View all literature mentions

p44/42 MAPK (Erk1/2) (3A7) Mouse mAb (antibody)

RRID:AB_10695739

This monoclonal targets p44/42 MAPK (Erk1/2)

View all literature mentions

JNK1 + JNK2 + JNK3(phospho T183+T183+T221) (phospho T183 + T183 + T221) antibody [EPR5693] (antibody)

RRID:AB_10973183

This monoclonal targets JNK1 + JNK2 + JNK3(phospho T183+T183+T221) (phospho T183 + T183 + T221) antibody [EPR5693]

View all literature mentions

TNF- Antibody (antibody)

RRID:AB_2240625

This polyclonal targets TNF-

View all literature mentions

p38 (phospho Y182) antibody (antibody)

RRID:AB_881848

This polyclonal targets p38 (phospho Y182)

View all literature mentions

p-CaMKII (22B1) (antibody)

RRID:AB_626786

This monoclonal targets Rat CaMKII, phospho (Thr286)

View all literature mentions

NMDAR2B antibody (antibody)

RRID:AB_1658870

This polyclonal targets NMDAR2B antibody

View all literature mentions